Optimizing labelling conditions of (213)Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy

BACKGROUND: (213)Bismuth ((213)Bi, T(1/2) = 45.6 min) is one of the most frequently used α-emitters in cancer research. High specific activity radioligands are required for peptide receptor radionuclide therapy. The use of generators containing less than 222 MBq (225)Ac (actinium), due to limited av...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Radiopharm Chem
Main Authors: Chan, Ho Sze, de Blois, Erik, Konijnenberg, Mark W., Morgenstern, Alfred, Bruchertseifer, Frank, Norenberg, Jeffrey P., Verzijlbergen, Fred J., de Jong, Marion, Breeman, Wouter A. P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5843812/
https://ncbi.nlm.nih.gov/pubmed/29564386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41181-016-0014-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados